{"entity":{"id":"nct06196671","kind":"trial","name":"Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer","aka":["PTCA199-8"],"tldr":"A phase 2 trial of h101 oncolytic adenovirus and camrelizumab in pancreatic cancer, run by Fudan University, not yet recruiting.","summary":"Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer is a phase 2, interventional study registered as NCT06196671 by Fudan University, with a registry enrolment figure of 30 participants, started 2026-12-01 and due to reach its primary completion in 2028-01-01. Interventions recorded: H101; Camrelizumab. Conditions listed: Pancreatic Cancer. Primary outcome: Overall survival，OS. Pancreatic eligibility wording from the registry: \"* Histologically or cytologically confirmed advanced pancreas adenocarcinoma\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06196671","url":"https://clinicaltrials.gov/study/NCT06196671"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":["checkpoint-inhibitor"],"targets":[],"drugs":["h101-oncolytic-adenovirus","camrelizumab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06196671","phase":"2","setting":"Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer","sponsor":"Fudan University","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06196671/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"}],"drug":[{"id":"camrelizumab","kind":"drug","name":"Camrelizumab","route":"/drugs/camrelizumab/"},{"id":"h101-oncolytic-adenovirus","kind":"drug","name":"H101 oncolytic adenovirus","route":"/drugs/h101-oncolytic-adenovirus/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}